US Patent No: 7,514,100

Number of patents in Portfolio can not be more than 2000

Controlled release hydrocodone formulations

1 Status Updates

Stats

ALSO PUBLISHED AS: 20040047907
ATTORNEY / AGENT: (SPONSORED)
 

Importance

Loading Importance Indicators... loading....

Abstract

A solid oral controlled-release dosage form of hydrocodone is disclosed, the dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt thereof, and controlled release material.

Loading the Abstract Image... loading....

First Claim

Related Publications

Loading Related Publications... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
PURDUE PHARMA L.P.STAMFORD, CT215

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Huang, Hua-Pin Englewood Cliffs, NJ 36 473
Masselink, John K Old Tappan, NJ 11 55
Oshlack, Benjamin New York, NY 145 3104
Tonelli, Alfred P Congers, NY 14 82

Cited Art

Patent Info (Count) # Cites Year
 
PURDUE PHARMA L.P. (25)
4,828,836 Controlled release pharmaceutical composition 127 1987
4,834,985 Controlled release pharmaceutical composition 160 1987
4,990,341 Controlled release hydromorphone composition 84 1989
5,266,331 Controlled release oxycodone compositions 92 1991
5,273,760 Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer 124 1991
5,286,493 Stabilized controlled release formulations having acrylic polymer coating 125 1992
5,549,912 Controlled release oxycodone compositions 80 1993
5,472,712 Controlled-release formulations coated with aqueous dispersions of ethylcellulose 109 1993
5,580,578 Controlled release formulations coated with aqueous dispersions of acrylic polymers 97 1993
5,478,577 Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level 82 1993
5,411,745 Powder-layered morphine sulfate formulations 60 1994
5,965,161 Extruded multi-particulates 60 1994
5,639,476 Controlled release formulations coated with aqueous dispersions of acrylic polymers 234 1995
5,508,042 Controlled release oxycodone compositions 80 1995
5,968,551 Orally administrable opioid formulations having extended duration of effect 88 1995
5,958,459 Opioid formulations having extended controlled released 51 1995
5,656,295 Controlled release oxycodone compositions 67 1996
5,681,585 Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer 56 1996
5,672,360 Method of treating pain by administering 24 hour oral opioid formulations 89 1996
6,143,322 Method of treating humans with opioid formulations having extended controlled release 63 1997
5,958,452 Extruded orally administrable opioid formulations 76 1997
6,103,261 Opioid formulations having extended controlled release 51 1999
6,294,195 Orally administrable opioid formulations having extended duration of effect 63 1999
6,733,783 Controlled release hydrocodone formulations 35 2001
2004/0266,807 Controlled release hydrocodone formulations 6 2004
 
EURO-CELTIQUE S.A. (11)
4,844,907 Pharmaceutical composition comprising analgesic and anti-inflammatory agent 97 1986
5,071,646 Pharmaceutical ion exchange resin composition 73 1989
5,356,467 Controlled release coatings derived from aqueous dispersions of zein 92 1993
5,500,227 Immediate release tablet cores of insoluble drugs having sustained-release coating 93 1993
5,670,172 Pharmaceutical spheroid formulation 44 1995
5,849,240 Method of preparing sustained release pharmaceutical compositions 59 1996
5,891,471 Pharmaceutical multiparticulates 50 1996
5,843,480 Controlled release diamorphine formulation 41 1996
5,879,705 Sustained release compositions of morphine and a method of preparing pharmaceutical compositions 54 1997
5,965,163 Substained release compositions and a method of preparing pharmaceutical compositions 58 1997
6,572,885 Orally administrable opioid formulations having extended duration of effect 19 2001
 
ALZA CORPORATION (7)
5,019,397 Aqueous emulsion for pharmaceutical dosage form 60 1988
5,024,842 Annealed coats 64 1990
5,460,826 Morphine therapy 59 1994
6,491,945 Hydrocodone therapy 12 1994
5,593,695 Morphine therapy 22 1995
5,866,161 Hydrocodone therapy 12 1996
5,667,805 Morphine therapy 15 1996
 
WARNER-LAMBERT COMPANY (4)
4,483,847 Process for the manufacture of a pharmaceutical composition with a retarded liberation of active material 62 1983
4,600,645 Process for treating dosage forms 54 1985
5,068,110 Stabilization of enteric coated dosage form 45 1989
5,167,964 Semi-enteric drug delivery systems and methods for preparing same 65 1992
 
ALPHARMA PHARMACEUTICALS, LLC (3)
5,202,128 Sustained release pharmaceutical composition 111 1990
5,330,766 Sustained release pharmaceutical composition 74 1993
5,378,474 Sustained release pharmaceutical composition 79 1993
 
FMC CORPORATION (3)
5,206,030 Film-forming composition and use for coating pharmaceuticals, foods and the like 39 1990
5,248,516 Film-forming composition: method of producing same and use for coating pharmaceuticals and foods and the like 29 1991
5,258,436 Film-forming composition; method of producing same and use for coating pharmaceuticals and foods and the like 20 1991
 
GACELL LABORATORIES AB (3)
4,557,925 Membrane-coated sustained-release tablets and method 86 1984
5,178,868 Dosage form 51 1991
5,520,931 Controlled release morphine preparation 29 1995
 
DRUGTECH CORPORATION (2)
5,122,384 Oral once-per-day organic nitrate formulation which does not induce tolerance 29 1989
5,133,974 Extended release pharmaceutical formulations 198 1990
 
ELAN CORPORATION, PLC (2)
4,609,542 New pharmaceutical forms for administration of medicaments by oral route, with programmed release 28 1985
5,637,320 Controlled absorption naproxen formulation for once-daily administration 35 1994
 
PURDUE PHARMA COMPANY, THE (2)
4,861,598 Controlled release bases for pharmaceuticals 96 1986
4,970,075 Controlled release bases for pharmaceuticals 75 1989
 
VIRGINIA COMMONWEALTH UNIVERSITY (2)
5,321,012 Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance 92 1993
5,502,058 Method for the treatment of pain 71 1994
 
AMERICAN CYANAMID COMPANY (1)
5,283,065 Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form 67 1992
 
ARCHIMEDES DEVELOPMENT LIMITED (1)
5,629,011 Composition for nasal administration 60 1994
 
ASAHI KASEI CHEMICALS CORPORATION (1)
5,384,130 Spherical seed cores, spherical granules and process for production thereof 35 1993
 
CADBURY ADAMS USA LLC (1)
4,894,234 Novel drug delivery system for antiarrhythmics 65 1988
 
CIBA-GEIGY CORPORATION (1)
4,548,990 Crosslinked, porous polymers for controlled drug delivery 82 1983
 
DEPOMED SYSTEMS, INC. (1)
5,007,790 Sustained-release oral drug dosage form 130 1989
 
DEUTSCHE BANK AG NEW YORK BRANCH (1)
4,983,730 Water soluble cellulose acetate composition having improved processability and tensile properties 49 1988
 
DUPHAR INTERNATIONAL RESEARCH B.V. (1)
5,219,575 Compositions with controlled zero-order delivery rate and method of preparing these compositions 16 1990
 
DUQUESNE UNIVERSITY OF THE HOLY GHOST, A CORP. OF PA. (1)
5,169,645 Directly compressible granules having improved flow properties 81 1989
 
EUROCELTIQUE S.A., 122, BOULEVARD DE LA PETRUSSE, LUXEMBOURG (1)
4,844,909 Controlled release hydromorphone composition 78 1987
 
F.H. FAULDING & CO. LIMITED (1)
5,196,203 Theophylline dosage form 37 1991
 
FISONS CORPORATION (1)
4,959,219 Coating barriers comprising ethyl cellulose 16 1988
 
FOREST LABORATORIES, INC. (1)
4,389,393 Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose 206 1982
 
GLATT GMBH (1)
5,132,142 Apparatus and method for producing pellets by layering power onto particles 44 1991
 
GRUENENTHAL GMBH (1)
5,601,842 Sustained release drug formulation containing a tramadol salt 40 1996
 
HOECHST AKTIENGESELLSCHAFT (1)
4,935,246 Process for the coating of granules 99 1988
 
MERCK SHARP & DOHME CORP. (1)
4,377,568 Preparation of aqueous alcoholic dispersions of pH sensitive polymers and plasticizing agents and a method of enteric coating dosage forms using same 41 1981
 
MERRELL DOW PHARMACEUTICALS INC. (1)
4,421,736 Sustained release diethylpropion compositions 53 1982
 
MILES INC. (1)
4,797,410 Suppression of withdrawal symptoms in opioid-induced tolerance or dependence 28 1987
 
NIPPON SHINYAKU CO., LTD. (1)
5,456,923 Method of manufacturing solid dispersion 88 1993
 
NIRO HOLDING A/S (1)
5,030,400 Process and an apparatus for agglomeration of a powdery material 57 1990
 
PFIZER INC. (1)
4,861,596 Rolled matrix device having enhanced ability to unroll and method for its production 7 1988
 
PHARMACIA & UPJOHN (1)
5,614,218 Controlled release preparation 27 1994
 
PUREUE PHARMA L.P. (1)
4,834,984 Controlled release dihydrocodeine composition 73 1987
 
RICHARDSON-VICKS INC. (1)
4,996,047 Sustained release drug-resin complexes 58 1988
 
RIJKSUNIVERSITEIT GRONINGEN (1)
4,708,874 Devices for the controlled release of active substances, as well as process for the preparation thereof 52 1986
 
ROHM GMBH (1)
4,520,172 Method for coating medicaments 39 1983
 
SHIN-ETSU CHEMICAL CO., LTD. (1)
4,385,078 Method for providing enteric coating on solid dosage forms and aqueous compositions therefor 57 1979
 
SHIONOGI & CO., LTD. (1)
5,023,089 Sustained-release preparations and the process thereof 44 1989
 
SPRING AG, PHARMAZEUTISCHE PRAEPARATE A SWISS CORP. (1)
5,292,461 Process for the production of pellets 46 1991
 
TAKEDA PHARMACEUTICAL COMPANY LIMITED (1)
5,026,560 Spherical granules having core and their production 96 1988
 
TCF BANK SAVINGS FSB N/K/A TCF NATIONAL BANK (1)
5,126,145 Controlled release tablet containing water soluble medicament 96 1990
 
VALEANT INTERNATIONAL BERMUDA (1)
5,518,730 Biodegradable controlled release flash flow melt-spun delivery system 144 1992
 
WATSON LABORATORIES, INC. (1)
4,806,337 Erodible matrix for sustained release bioactive composition 87 1986
 
ZYMA SA (1)
4,728,513 Granular delayed-release form of pharmaceutically active substances 55 1986
 
OTHER [CHECK PATENT PROFILE FOR ASSIGNMENT INFORMATION] (2)
4,464,378 Method of administering narcotic antagonists and analgesics and novel dosage forms containing same 108 1981
4,443,428 Extended action controlled release compositions 53 1982

Patent Citation Ranking

Forward Cites

Patent Info (Count) # Cites Year
 
DEPOMED, INC. (3)
8,377,453 Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic 0 2009
8,372,432 Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic 0 2009
8,394,408 Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic 0 2012
 
PURDUE PHARMA L.P. (1)
7,846,476 Once-a-day oxycodone formulations 3 2002
 
OTHER [CHECK PATENT PROFILE FOR ASSIGNMENT INFORMATION] (1)
8,445,018 Abuse resistant drug formulation 0 2008

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Oct 7, 2016
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 7, 2020
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00